Surgical management and prognostic factors in patients with spinal metastatic tumors / 中华外科杂志

ABSTRACT

<p><b>OBJECTIVE</b>To identify the survival prognostic factors and clinical outcome of the patients with spinal metastatic tumors and to discuss the surgical treatment strategy of spinal metastatic tumors.</p><p><b>METHODS</b>The patients with spinal metastatic tumors who received surgeries during January 2003 to June 2012 were enrolled. The survival was analyzed by Kaplan-Meier survival curve. The prognostic factors, divided into patient-related factors, tumor-related factors and therapy-related factors, were analyzed univariately and multivariately by Cox comparative hazard model.</p><p><b>RESULTS</b>There were 453 patients were enrolled in research including 263 male and 190 female patients with an average age of (56 ± 13) years (10-86 years). The median postoperative survival was 9 months. Local recurrences and peri-operative complications were found in 78 (17.2%) and 72 (15.9%) patients, respectively. Univariate analysis showed the significant prognostic factors for postoperative survival included poor preoperative general condition (χ(2) = 4.16), severe preoperative neurologic deficit(χ(2) = 10.23), not receiving bisphosphonate therapy(χ(2) = 10.47), short disease-free interval before spinal metastasis (χ(2) = 23.31), spinal metastasis as the first manifestation (χ(2) = 10.94), rapid-growth primary tumor(χ(2) = 15.45), visceral metastasis (χ(2) = 4.10), not receiving postoperative radiotherapy(χ(2) = 18.10) and not receiving post-operative sensitive systemic therapy(χ(2) = 11.20) (P < 0.05). Multivariate analysis showed the independent prognostic factors include severe preoperative neurologic deficit (P = 0.012, 95%CI 1.11-2.30), short disease-free interval before spinal metastasis (P = 0.023, 95%CI1.05-1.83), rapid-growth primary tumor (P = 0.000, 95%CI1.74-3.06), visceral metastasis (P = 0.008, 95%CI 1.08-1.68), not receiving postoperative radiotherapy (P = 0.000, 95%CI1.38-2.35) and not receiving post-operative sensitive systemic therapy (P = 0.045, 95%CI1.01-1.58).</p><p><b>CONCLUSION</b>The prognostic factors for survival are useful for determining the indication of operation and improving survival and clinical outcome for patients with spinal metastatic tumors.</p>